Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Change in Accured Expenses (2020 - 2025)

Tango Therapeutics has reported Change in Accured Expenses over the past 6 years, most recently at $4.5 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $4.5 million for Q4 2025, up 201.01% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (down 2.65% YoY), and the annual figure for FY2025 was $1.1 million, down 2.65%.
  • Change in Accured Expenses for Q4 2025 was $4.5 million at Tango Therapeutics, up from $1.6 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for TNGX hit a ceiling of $4.5 million in Q4 2025 and a floor of -$6.7 million in Q1 2023.
  • Median Change in Accured Expenses over the past 5 years was $1.3 million (2024), compared with a mean of $583350.0.
  • Biggest five-year swings in Change in Accured Expenses: surged 88020.16% in 2021 and later crashed 4169.43% in 2023.
  • Tango Therapeutics' Change in Accured Expenses stood at $35000.0 in 2021, then surged by 4985.71% to $1.8 million in 2022, then skyrocketed by 124.55% to $4.0 million in 2023, then plummeted by 62.7% to $1.5 million in 2024, then soared by 201.01% to $4.5 million in 2025.
  • The last three reported values for Change in Accured Expenses were $4.5 million (Q4 2025), $1.6 million (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.